CP

China Pharma Holdings IncNYSE-MKT CPHI Stock Report

Last reporting period 30 Sep, 2023

Updated 21 Nov, 2024

Last price

Market cap $B

0.004

Micro

Exchange

XASE - Nyse MKT LLC

CPHI Stock Analysis

CP

Uncovered

China Pharma Holdings Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-50/100

Low score

Market cap $B

0.004

Dividend yield

Shares outstanding

5.164 B

China Pharma Holdings Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Haikou, Hainan and currently employs 236 full-time employees. The company went IPO on 2000-02-15. China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.

View Section: Eyestock Rating